2017
DOI: 10.15761/crr.1000115
|View full text |Cite
|
Sign up to set email alerts
|

A rare case of humoral hypercalcemia of malignancy resulting from urothelial carcinoma

Abstract: Background: Humoral Hypercalcemia of malignancy is a common cause of hypercalcemia. This is typically associated with cancers of the head and neck and lung cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…Fuller Albright differentiated hypercalcemia from skeletal invasion from that due to humoral cytokine expression by malignancies, which he termed humoral hypercalcemia of malignancy (HHCM) [ 17 ]. The mechanisms for HHCM include osteolysis at sites of bone metastases in 20% of cases, tumor secretion of PTHrP, and, less commonly, an extrarenal site of calcitriol or ectopic PTH production (< 1% each) [ 18 ]. A low PTH excludes an ectopic production site.…”
Section: Discussionmentioning
confidence: 99%
“…Fuller Albright differentiated hypercalcemia from skeletal invasion from that due to humoral cytokine expression by malignancies, which he termed humoral hypercalcemia of malignancy (HHCM) [ 17 ]. The mechanisms for HHCM include osteolysis at sites of bone metastases in 20% of cases, tumor secretion of PTHrP, and, less commonly, an extrarenal site of calcitriol or ectopic PTH production (< 1% each) [ 18 ]. A low PTH excludes an ectopic production site.…”
Section: Discussionmentioning
confidence: 99%